The Effects os methylfenidate or amphetamines on concentration in adults with attention deficit disorder with hyperactivity
UMA REVISÃO SISTEMÁTICA
Keywords:
Attention Deficit Hyperactivity Disorder, Adult, Methylphenidate, Amphetamine, ConcentrationAbstract
Objective: To understand the effects of drug therapy with Methylphenidate (MTF) or Amphetamines (ANF) on concentration in adults with Attention Deficit Hyperactivity Disorder (ADHD). Methodology: This is a systematic review of the literature. Results: Of the studies analyzed, 42.86% focused on the positive effects of MTF, while 14.29% investigated the benefits of ANF. Additionally, 28.57% of studies examined the beneficial effects of alternative central nervous system stimulants such as Modafinil and Manzidol, and 14.29% addressed the benefits of combining both treatment classes in the management of ADHD. Conclusion: We observed that MTF influences rewards, and ANF improves executive function and sustained attention, in addition to full attention. The need for personalized approaches, considering symptom severity and side effects, is clear, as is the combination of drug and psychotherapeutic therapies for comprehensive results. This highlights the relevance of an individualized approach in managing ADHD in adults.
Downloads
References
Weibel S, Menard O, Ionita A, Boumendjel M, Cabelguen C, Kraemer C, Micoulaud-Franchi JA, Bioulac S, Perroud N, Sauvaget A, Carton L, Gachet M, Lopez R. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults. Encephale. 2020; 46 (1): 30-40. Available from: https://pubmed.ncbi.nlm.nih.gov/31610922/
Magnus W, Nazir S, Anilkumar AC, et. al. Attention Deficit Hyperactivity Disorder.Treasure Island: StatPearls. 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441838/
De Assis Azevedo MC, Rodrigues CFP, Colares FB, da Cruz TTA. Tratamento farmacológico em pacientes com TDAH com ênfase no uso do metilfenidato: Revisão sistemática. Brazilian Journal of Development. 2021; 7 (11): 107876-107900.
Asherson P. O Transtorno de Déficit de Atenção com Hiperatividade (TDAH) e a Genética. Enciclopédia sobre o Desenvolvimento na Primeira Infância. Reino Unido: Kings College London, 2010. Disponível em: https://www.enciclopedia-crianca.com/hiperatividade-e-deficit-de-atencao-tdah/segundo-especialistas/o-transtorno-de-deficit-de-atencao#:~:text=Os%20genes%20do%20sistema%20dopamina,como%20SNAP%2D25%20e%20CDH13.
Serra LG. Fatores ambientais e a autorregulação emocional deficiente em crianças e/ou adolescentes com transtorno do déficit de atenção e hiperatividade-tdah. Universidade Federal de São Paulo, 2015. Disponível em: https://repositorio.unifesp.br/bitstream/handle/11600/46290/Disserta%c3%a7%c3%a3o%20de%20Mestrado%20-%20Lilian%20Grecu%20Serra.pdf?sequence=1&isAllowed=y
Parks KMA, Cardy JEO, Woynaroski TG, Sehl CG, Stevenson RA. Investigating the Role of Inattention and/or Hyperactivity/impulsivity in Language and Social Functioning Using a Dimensional Approach. J. Commun. Disord. 2021; 89: 106036. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862713/
Castro CXL, de Lima RF. Consequências do transtorno do déficit de atenção e hiperatividade (TDAH) na idade adulta. Revista Psicopedagogia. 2018; 35 (106): 61-72. Recuperado em 14 de setembro de 2022. Disponível em: http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S0103-84862018000100008
Da Silva MM, Vieira MRV, Barcellos GM, Rocha PLM, Assunção DS, Tonin DB, Rezende GS. Revisão bibliográfica: TDAH em adultos. Brazilian Journal of Development. 2022; 8 (4), 29571-29578. Disponível em: https://www.brazilianjournals.com/index.php/BRJD/article/view/46936
Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Cipriani, A. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet Psychiatry; 2018; 5 (9): 727-738. Available from: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(18)30269-4/fulltext
de la Torre R, Farré M, Navarro M, Pacifici R, Zuccaro P, Pichini S. Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. Clin Pharmacokinet. 2004;43(3):157-85. Available from: https://pubmed.ncbi.nlm.nih.gov/14871155/
Jaeschke RR, Sujkowska E, Sowa-Kućma M. Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review. Psychopharmacology. 2021; 238: 2667–2691. Available from: https://pubmed.ncbi.nlm.nih.gov/34436651/
Golan D, Tashjiam AH, Armstrong EJ, Armstrong AW. Princípios de farmacologia: a base fisiopatológica da farmacoterapia. 3ed. Guanabara Koogan; 2009.
Gopalakrishnan S, Ganeshkumar P. Systematic Reviews and Meta-analysis: Understanding the Best Evidence in Primary Healthcare. J. Family Med. Prim. Care. 2013 Jan;2(1):9-14. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894019/#:~:text=Systematic%20reviews%20aim%20to%20identify,more%20accessible%20to%20decision%20makers.
Donato H, Donato M. Etapas na Condução de uma Revisão Sistemática. Acta. Med. Port. 2019; 32 (3): 227-235.
Galvão Taís Freire, Pereira Mauricio Gomes. Revisões sistemáticas da literatura: passos para sua elaboração. Epidemiol. Serv. Saúde. 2014; 23 (1): 183-84. Disponível em: http://scielo.iec.gov.br/scielo.php?script=sci_arttext&pid=S1679-49742014000100018#:~:text=Os%20m%C3%A9todos%20para%20elabora%C3%A7%C3%A3o%20de,%3B%20e%20(8)%20reda%C3%A7%C3%A3o%20e
Furukawa E, Costa RQM, Hoefle PBS, Vigne P, Monteiro M, Wickens JR, MollJ, Tripp G, Mettos T. Methylphenidate modifies reward cue responses in adults with ADHD: An fMRI study. Neuropharmacology. 2020; 162 (1): 0028-3908. Available from: https://www.sciencedirect.com/science/article/pii/S0028390819303995?via%3Dihub#sec5
Brown TE, Chen J, Robertson B. Relationships Between Executive Function Improvement and ADHD Symptom Improvement With Lisdexamfetamine Dimesylate in Adults With ADHD and Executive Function Deficits: A Post Hoc Analysis. Prim Care Companion CNS Disord. 2020; 22 (3): 19m02559. Available from: https://pubmed.ncbi.nlm.nih.gov/32470230/
Bahn GH, Seo K. Combined Medication with Stimulants and Non-stimulants for Attention-deficit/hyperactivity Disorder. Clin Psychopharmacol Neurosci. 2021; 19 (4): 705-711. Available from: https://pubmed.ncbi.nlm.nih.gov/34690125/
Lam AP, Matthies S, Graf E, et al. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial. JAMA Netw Open. 2019; 2 (5):e194980. Available from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2734811
Thomas EM, Freeman TP, Poplutz P, Howden K, Hindocha C, Bloomfield M, Kamboj SK. Stimulating meditation: a pre-registered randomised controlled experiment combining a single dose of the cognitive enhancer, modafinil, with brief mindfulness training. J Psychopharmacol. 2021; 35 (6): 621-630. Available from: https://pubmed.ncbi.nlm.nih.gov/33645313/
Wigal TL, Newcorn JH, Handal N, Wigal SB, Mulligan I, Schmith V, Konofal E. A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS Drugs. 2018; 32 (3): 289-301. Available from: https://pubmed.ncbi.nlm.nih.gov/29557078/
Edvinsson D, Ekselius L. Long-Term Tolerability and Safety of Pharmacological Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A 6-Year Prospective Naturalistic Study. J Clin Psychopharmacol. 2018; 38 (4): 370-375. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039396/#:~:text=The%20main%20finding%20is%20that,at%20least%20for%20most%20patients
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
